Introduction
The landscape of healthcare technology is shifting rapidly. The rise of Software as a Medical Device (SaMD) demands faster innovation cycles than traditional Waterfall development models can provide.
However, medical device manufacturers face a unique challenge. There is historical friction between the strict regulatory rigor required by FDA 21 CFR Part 820 and the fast-paced, iterative nature of modern Agile software development.
Fortunately, AAMI TIR45 serves as the definitive bridge for this gap. This standard functions as the ultimate Agile development compliance guide, allowing teams to utilize Agile methodologies without compromising patient safety or regulatory compliance
What is AAMI TIR45?
AAMI TIR45 is a comprehensive technical information report and guidance document. It focuses explicitly on the use of Agile practices in the development of medical device software.
Initially released in 2012, it proved that Agile methodologies possess the necessary rigor for critical medical systems. It dispelled the myth that Agile cannot adhere to the FDA’s Quality System Regulation (QSR).
The updated AAMI TIR45 2023 standard evolved to embrace modern realities. It acknowledges continuous integration and continuous delivery (CI/CD) pipelines, automated testing, and provides greater alignment with the ISO 14971:2019 risk management framework.
FDA Guidelines for Agile Medical Device Development
Does the FDA Accept Agile Methodology?
The short answer is an absolute yes. The FDA does not mandate the use of the Waterfall methodology for medical device software development.
In fact, the FDA officially recognized AAMI TIR45 as a consensus standard. This provides regulatory assurance that Agile practices can be fully aligned with safety and compliance requirements.
Implementing Agile within FDA QSR Constraints
Implementing Agile does not mean abandoning quality. When applied correctly, Agile practices can significantly enhance an organization’s Quality Management System (QMS).
By focusing on continuous testing and documented evidence in Agile MedTech, teams can satisfy the strict design control requirements of FDA 21 CFR Part 820. Agile allows for continuous assessment of quality through regular testing and integration.
Mapping IEC 62304 Activities to Agile Lifecycle
Agile vs Waterfall for Medical Device Software
Traditional linear models like Waterfall are often slow and costly when changes are required late in the lifecycle. Many mistakenly believe IEC 62304 compliance requires Waterfall, but this is a myth.
The IEC 62304 standard simply requires documented lifecycle activities and traceable evidence of safety. Agile vs Waterfall for medical device software is not a regulatory debate; it is a business decision where Agile often wins by delivering continuous feedback.
Structuring the Layers: Story, Sprint, Release, and Product
AAMI TIR45 expertly maps the linear requirements of IEC 62304 into an iterative Agile framework. It breaks the Agile lifecycle down into four distinct layers: Product, Release, Iteration (Sprint), and Story.
IEC 62304 activities are distributed across these layers. For instance, high-level software architecture might happen at the Release layer, while detailed design, coding, and unit testing are pushed down to the specific User Story layer.
Agile Risk Management and Traceability for SaMD
Creating a Living Traceability Matrix for SaMD
Maintaining compliance requires proving that every requirement is tested and every risk is mitigated. Relying on static spreadsheets for this is a nightmare prone to human error.
Instead, teams must create a living traceability matrix using automated traceability matrix software. This establishes real-time, end-to-end traceability between requirements, source code, test cases, and risk controls.
ISO 14971 Risk Management in Sprints
Agile enables continuous risk management. By pushing compliance tasks down to the User Story layer, teams achieve early discovery and continuous risk prioritization.
This means ISO 14971 risk management becomes an ongoing activity. Hazards are evaluated and mitigated continuously during each iterative sprint, rather than waiting for a massive review at the end of the project.
H3: Definition of Done (DoD) in Medical Device Software
To satisfy AAMI TIR45, the Definition of Done (DoD) in medical device software must be updated to include strict regulatory evidence.
A user story is never truly “done” just because the code works. The DoD must require that code reviews are finished, unit tests pass, the risk management file is updated, and all traceability links are confirmed before closing a sprint.
Streamlining AAMI TIR45 Compliance with Visure Solutions
Implementing AAMI TIR45 and managing continuous compliance manually is a logistical burden that slows down development. Spreadsheets simply cannot handle the dynamic nature of Agile medical device software.
This is where the Visure Requirements ALM Platform steps in as the ultimate solution. It is a premier requirements management software for MedTech that seamlessly bridges the Agile-Waterfall gap.
Visure automatically compiles Agile sprint data to meet formal IEC 62304 compliance structures. It offers:
- An automated Risk Traceability Matrix (RTM) generated in real-time.
- Native, bi-directional Jira integration to sync hardware and software engineering teams.
- Out-of-the-box compliance templates for ISO 13485, ISO 14971, and FDA 21 CFR Part 11.
Conclusion
Agile methodologies and strict regulatory rigor are not mutually exclusive. AAMI TIR45 provides the exact framework needed to develop safer, high-quality SaMD without sacrificing development speed.
By updating the Definition of Done and focusing on continuous compliance, teams can gather iterative feedback while meeting all medical device regulatory requirements. With the right alignment of Agile practices and automated QMS tools, organizations can dramatically improve both speed-to-market and overall patient safety.
Check out the free trial at Visure and experience how AI-driven change control can help you manage changes faster, safer, and with full audit readiness.
